U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. CDER Conversations
  1. News & Events for Human Drugs

CDER Conversations

Reflecting on Biosimilar User Fee Amendments (BsUFA) II and preparing for the BsUFA III reauthorization process

In this CDER Conversation, Dr. Sarah Yim, M.D., director of the Center for Drug Evaluation and Research (CDER) Office of Therapeutic Biologics and Biosimilars discusses BsUFA.

BsUFA allows FDA to collect user fees, which create a reliable funding source that helps ensure the timely review of biosimilar and interchangeable biological products.


More with Sarah Yim


Resources For You

Back to Top